Greenwich LifeSciences Inc XNAS: GLSI

Greenwich LifeSciences Inc Live Share Price Today, Share Analysis and Chart

about

Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9 amino acid transmembrane pepti...

Read More

9.80 0.07 (0.72%)

47.73% Fall from 52W High

43,511 XNAS Volume

XNAS 22 May, 2025 4:00 PM (EDT)

Not Eligible
-
Expensive Valuation
0.7 / 100
Technically Neutral
37.1 / 100

Greenwich LifeSciences Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..

Greenwich LifeSciences Inc FAQ

How is Greenwich LifeSciences Inc today?
Greenwich LifeSciences Inc today is trading in the green, and is up by 0.72% at 9.80.
Greenwich LifeSciences Inc is currently trading up 0.72% on an intraday basis. In the past week the stock rose 4.03%. stock has been down -17.99% in the past quarter and fell -27.62% in the past year. You can view this in the overview section.